720
Participants
Start Date
November 30, 2007
Primary Completion Date
February 28, 2010
Study Completion Date
February 28, 2010
13 valent Pneumococcal Conjugate Vaccine
0.5 ml dose 13vPnC will be administered into the deltoid muscle at year 0 and year 1
13 valent Pneumococcal Conjugate Vaccine
0.5 ml dose 13vPnC will be administered into the deltoid muscle at year 0 and 0.5 ml dose 23vPS at year 1
13 valent Pneumococcal Conjugate Vaccine
0.5 ml dose 23vPS will be administered into the deltoid muscle at year 0 and 0.5 ml dose 13vPnC at year 1
23-valent Pneumococcal Polysaccharide Vaccine
0.5 ml dose 23vPS will be administered into the deltoid muscle at year 0 and 0.5 ml dose 13vPnC at year 1
23-valent Pneumococcal Polysaccharide Vaccine
0.5 ml dose 13vPnC will be administered into the deltoid muscle at year 0 and 0.5 ml dose 23vPS at year 1
Pfizer Investigational Site, Raleigh
Pfizer Investigational Site, Pembroke Pines
Pfizer Investigational Site, Bristol
Pfizer Investigational Site, Cincinnati
Pfizer Investigational Site, Boise
Pfizer Investigational Site, Chandler
Wyeth is now a wholly owned subsidiary of Pfizer
INDUSTRY